AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
The drugmaker’s revenue rose 5% when adjusted for currency changes, driven by growth in oncology sales.
Connecting Global Economies
Flash News
Wife of Chiefs offensive coordinator Eric Bieniemy shot: Report
Nvidia, Other Tech Giants Launch AI Defense Alliance Following OpenAI Hacking Incident
Jim Cramer’s top 10 things to watch in the stock market Monday
Fabien Frankel’s Criston Cole Dies in Battle
Mercedes’ top scout Gwen Lagrue joins Red Bull as director of junior programme
Nvidia Bets on Ilya Sutskever’s New AI Lab to Expand Compute Reach
Iran halts strikes as Trump gives space to talks
fire cloud ravaging France, Spain regions
NFL training camp 2026 live updates: News, injuries and more from around the league
AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
Monday, July 27, 2026